Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 810-812, 2008.
Article Dans Chinois | WPRIM | ID: wpr-360551

Résumé

<p><b>OBJECTIVE</b>To observe the effects of Colquhounia root tablet (CRT) combined with immunosuppressive protocal in treating patients with chronic allograft nephropathy (CAN).</p><p><b>METHODS</b>Thirty-three patients of CAN, with urinary protein > or = 1.0 g/24 h and serum creatinine (SCr) > or =150 (micromol/L), were assigned to two groups, the 15 in the treated group treated with CRT combining modified immunosuppressive protocol (IIP) therapy and the 18 in the control group treated with IIP alone, all for 6 months. The clinical efficiency, 24 h urinary protein and clearance of creatinine (CCr) were observed.</p><p><b>RESULTS</b>The effective rate in the treated group [60% (9/15 cases)] was significantly higher than that in the control group [22.0% (4/18 cases), P < 0.05], and the lowering of 24 h urinary protein in the former was more significant than in the latter at the end of the 3rd and the 6th month of treatment (P < 0.05). At the end of 12-month follow-up, SCr and CCr level were stable in the treated group, while in the control group, SCr level increased and CCr level decreased significantly (P < 0.05), comparisons of the two indexes between the two groups at the end of the therapeutic course and follow-up study all showed significant differences (P < 0.05). Serum creatinine doubling to baseline were seen in 2 patients of the treated group and 7 of the control group. One patient in the treated group and 4 in the control group entered the end stage of renal disease.</p><p><b>CONCLUSION</b>Therapy with CRT combined IIP seems to be more effective in reducing urinary protein excretion in patients with CAN than that with IIP alone, and a more favorable renal function preserving effect of the former is shown by a short-term follow-up.</p>


Sujets)
Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Association de médicaments , Médicaments issus de plantes chinoises , Utilisations thérapeutiques , Immunosuppresseurs , Utilisations thérapeutiques , Maladies du rein , Traitement médicamenteux , Allergie et immunologie , Chirurgie générale , Transplantation rénale , Lamiaceae , Chimie , Racines de plante , Chimie , Transplantation homologue
2.
Journal of Central South University(Medical Sciences) ; (12): 451-454, 2007.
Article Dans Chinois | WPRIM | ID: wpr-813862

Résumé

OBJECTIVE@#To determine the influence factors of perinatal stage transmission of hepatitis B virus (HBV) and to provide scientific evidence for the prevention of perinatal stag transmission of HBV.@*METHODS@#A 1:1 matched nested case-control study was conducted, and 141 pair of pregnant women with HBsAg-positive and their newborns were enrolled. A questionnaire was performed and blood-related indicators were detected. The data were dealt with single factor analysis and conditional logistic regression analysis using SPSS 13.0 and SAS 8.1.@*RESULTS@#Single factor paired Chi-square test showed that education, first class family history, disfunction of liver, serum glutamic-pyruvic transaminase, systematic treatment, intrahepatic cholestasis of pregnancy (ICP), fetal distress, and vaccinating hepatitis B immune globulin (HBIG) were the risk factors of perinatal stage transmission of HBV. Conditional logistic regression analysis indicated that first class family history, vaccinating HBIG, systematic treatment, and ICP were the risk factors of perinatal stage transmission of HBV.@*CONCLUSION@#For women with HB-sAg-positive, active treatment, the standard vaccination of HBIG, and preventing and controlling the incidence of ICP may reduce the incidence of perinatal stage transmission of HBV.


Sujets)
Adulte , Femelle , Humains , Nouveau-né , Grossesse , Études cas-témoins , Hépatite B , Sang , Antigènes de surface du virus de l'hépatite B , Sang , Virus de l'hépatite B , Allergie et immunologie , Immunoglobulines , Utilisations thérapeutiques , Transmission verticale de maladie infectieuse , Modèles logistiques , Complications infectieuses de la grossesse , Traitement médicamenteux , Virologie
3.
Chinese journal of integrative medicine ; (12): 180-184, 2007.
Article Dans Anglais | WPRIM | ID: wpr-282414

Résumé

<p><b>OBJECTIVE</b>To observe the effect of TCM therapy for detoxification, removing stasis, and nourishing yin on corticosteroid-induced hyperlipemia in patients with systemic lupus erythematosus (SLE), and to investigate its mechanism.</p><p><b>METHODS</b>One hundred and seventy patients with SLE were randomly assigned to the integrative medicine group (IM group) and the Western medicine group (WM group), 85 in each group. Also, 30 healthy subjects selected from blood donors were enrolled in the normal control (NC) group. All patients were treated mainly with prednisone, while those in the IM group were given TCM therapy additionally, and the therapeutic course for both groups was 6 successive months. The changes of serum total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C) and apolipoprotein A (ApoA) were determined and observed. A 2-year follow-up study was carried out in 16 patients of the WM group and 25 of the IM group.</p><p><b>RESULTS</b>Before treatment, no significant difference had been found among the three groups in the serum levels of lipids and lipoproteins. After the 6-month treatment, as compared with the WM group, the IM group showed lower levels of TC, TG, LDL-C, and VLDL-C (P<0.05 or P<0.01) and higher levels of HDL-C and ApoA (P<0.05). A similar effect was also shown by the follow-up study in the IM group (P<0.05 or P<0.01).</p><p><b>CONCLUSION</b>TCM therapy for detoxification, removing stasis, and nourishing yin can effectively regulate the levels of serum lipids and lipoproteins in preventing and treating SLE patients with corticosteroid-induced hyperlipemia.</p>


Sujets)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Hormones corticosurrénaliennes , Études de suivi , Hyperlipidémies , Inactivation métabolique , Lipoprotéines , Sang , Lupus érythémateux disséminé , Thérapeutique , Yin-yang
SÉLECTION CITATIONS
Détails de la recherche